Proportion of participants who discontinued medication and did not develop rebound SEI within 21 days (higher is favored) · epidemic keratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants who had evidence of adenoviral eradication within 14 days of treatment (higher is favored) · epidemic keratoconjunctivitis
1 finding from 1 review
Proportion of initially unaffected fellow eyes that had signs/symptoms of infection within 7 days of onset of signs/symptoms in the first eye (lower is favored) · epidemic keratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants with resolution of signs within 10 days of treatment (higher is favored) · epidemic keratoconjunctivitis
1 finding from 1 review
Proportion of participants in whose eyes SEIs had developed within 30 days of treatment initiation (lower is favored) · epidemic keratoconjunctivitis
It is very uncertain whether any intervention changes proportion of participants in whose eyes SEIs had developed within… compared with artificial tears or saline (very low certainty).
1 finding from 1 review
Proportion of participants in whose eyes SEI had disappeared within 21 days of treatment (higher is favored) · epidemic keratoconjunctivitis
It is very uncertain whether any intervention changes proportion of participants in whose eyes SEI had disappeared within… compared with artificial tears or saline (very low certainty).
1 finding from 1 review
Proportion of participants who discontinued medication and did not develop rebound SEI within 21 days (higher is favored) · epidemic keratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proportion of participants who had evidence of adenoviral eradication within 14 days of treatment (higher is favored) · epidemic keratoconjunctivitis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Proportion of initially unaffected fellow eyes that had signs/symptoms of infection within 7 days of onset of signs/symptoms in the first eye (lower is favored) · epidemic keratoconjunctivitis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean number of days from treatment initiation to resolution of symptoms or signs (shorter is favored) · epidemic keratoconjunctivitis
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Seizure recurrence at 5 years after randomisation · patients with first unprovoked seizure
Immediate treatment leads to lower seizure recurrence at 5 years after randomisation compared with controls (high certainty).
1 finding from 1 review
Five year immediate remission after randomisation · patients with first unprovoked seizure
Immediate treatment leads to higher five‐year immediate remission after randomisation compared with controls (high certainty).
1 finding from 1 review
Five year remission at any time after randomisation · patients with first unprovoked seizure
Immediate treatment showed no clear difference in five‐year remission at any time after randomisation compared with controls (high certainty).
1 finding from 1 review
Seizure recurrence at 1 year after randomisation · patients with first unprovoked seizure
Immediate treatment leads to lower seizure recurrence at 1 year after randomisation compared with controls (high certainty).
1 finding from 1 review
Mortality at the end of the · patients with first unprovoked seizure
Immediate treatment showed no clear difference in mortality at the end of the compared with controls (high certainty).
1 finding from 1 review
Adverse events (control ‐ deferred treatment) · patients with first unprovoked seizure
Immediate treatment probably leads to higher adverse events (control ‐ deferred treatment) compared with controls (moderate certainty).
1 finding from 1 review
Adverse events (control ‐ no treatment) · patients with first unprovoked seizure
Immediate treatment may leads to higher adverse events (control ‐ no treatment) compared with controls (low certainty).
1 finding from 1 review
Intervention not reported
Change from baseline in blood eosinophils (cells x 10*9/L) · children and adults with asthma
1 finding from 1 review
Intervention not reported
Change from baseline in Periostin (ng/mL) · children and adults with asthma
1 finding from 1 review
Intervention not reported
Percentage reduction from baseline in maintenance OCS dose · children and adults with asthma
1 finding from 1 review